Health economics in drug development

Author：

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.412, 2003-01, pp. : 3-5

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Future Costs, Risks and Rewards of Drug Development: The Economics of Pharmacogenomics

By Cook Joseph

PharmacoEconomics, Vol. 27, Iss. 5, 2009-05 ,pp. : 355-363

Adis International

Access to resources Recommend Favorite

Comment on “The Economics of Follow-On Drug Research and Development: Trends in Entry Rates and the Timing of Development”

By Hollis Aidan

PharmacoEconomics, Vol. 23, Iss. 12, 2005-01 ,pp. : 1187-1192

Adis International

Access to resources Recommend Favorite

The Economics of Follow-On Drug Research and Development: Trends in Entry Rates and the Timing of Development – The Authors' Reply

By DiMasi Joseph A. Paquette Cherie

PharmacoEconomics, Vol. 23, Iss. 12, 2005-01 ,pp. : 1193-1202

Adis International

Access to resources Recommend Favorite

Health economics and outcomes research: informing companion diagnostic development, guidelines, adoption and reimbursement

By Lee Jim Lopez-Rios Fernando

Expert Review of Molecular Diagnostics, Vol. 13, Iss. 5, 2013-06 ,pp. : 413-415

Informa Healthcare

Access to resources Recommend Favorite

Drug-Glycosidation and Drug Development

Mini Reviews in Medicinal Chemistry, Vol. 13, Iss. 4, 2013-04 ,pp. : 584-596

Bentham Science Publishers

Access to resources Recommend Favorite